213 related articles for article (PubMed ID: 11567755)
21. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of varicella zoster antibodies among children with malnutrition, malignancies and HIV infection.
Admani B; Macharia WM; Were F
East Afr Med J; 2008 Oct; 85(10):480-6. PubMed ID: 19537424
[TBL] [Abstract][Full Text] [Related]
23. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
Koturoglu G; Kurugol Z; Turkoglu E
Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
[TBL] [Abstract][Full Text] [Related]
24. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.
Kose S; Mandiracioglu A; Senger SS; Ulu Y; Cavdar G; Gol B; Gurbuz I; Sariavci S; Nohutcu N
J Infect Public Health; 2013 Apr; 6(2):115-9. PubMed ID: 23537824
[TBL] [Abstract][Full Text] [Related]
26. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
Kavaliotis J; Petridou S; Karabaxoglou D
Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
[TBL] [Abstract][Full Text] [Related]
27. Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC.
Suo L; Lu L; Chen M; Pang X
BMC Infect Dis; 2015 Nov; 15():509. PubMed ID: 26554449
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
29. The seroepidemiology of varicella in Italy.
Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
[TBL] [Abstract][Full Text] [Related]
30. Three year seroepidemiological study of varicella-zoster virus in São Paulo, Brazil.
Yu AL; Costa JM; Amaku M; Pannuti CS; Souza VA; Zanetta DM; Burattini MN; Massad E; Azevedo RS
Rev Inst Med Trop Sao Paulo; 2000; 42(3):125-8. PubMed ID: 10887369
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
[TBL] [Abstract][Full Text] [Related]
32. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
[TBL] [Abstract][Full Text] [Related]
33. Seroepidemiology of varicella-zoster virus in Bangladesh.
Saha SK; Darmstadt GL; Hanif M; Khan R
Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia.
Bartoloni A; Bartalesi F; Roselli M; Mantella A; Dini F; Carballo ES; Barron VP; Paradisi F
Trop Med Int Health; 2002 Jun; 7(6):512-7. PubMed ID: 12031073
[TBL] [Abstract][Full Text] [Related]
35. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico.
Alvarez y Muñoz MT; Torres J; Damasio-Santana L; Gómez A; Fernández-Quintanilla G; Tapia-Conyer R; Muñoz O
Arch Med Res; 1999; 30(1):60-3. PubMed ID: 10071427
[TBL] [Abstract][Full Text] [Related]
37. Age related seroprevalence of antibodies to varicella in India.
Lokeshwar MR; Agrawal A; Subbarao SD; Chakraborty MS; Ram Prasad AV; Weil J; Bock HL; Kanwal S; Shah RC; Shah N
Indian Pediatr; 2000 Jul; 37(7):714-9. PubMed ID: 10906803
[TBL] [Abstract][Full Text] [Related]
38. A seroepidemiological study of Varicella-Zoster virus in Taipei City.
Lin YJ; Huang LM; Lee CY; Chih TW; Lee PL; Chang LY; Hsu CM
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):11-5. PubMed ID: 8936004
[TBL] [Abstract][Full Text] [Related]
39. Seroprevalence of varicella in the French population.
Khoshnood B; Debruyne M; Lançon F; Emery C; Fagnani F; Durand I; Floret D
Pediatr Infect Dis J; 2006 Jan; 25(1):41-4. PubMed ID: 16395101
[TBL] [Abstract][Full Text] [Related]
40. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
